| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 31,832 | 22,260 |
| Effect of foreign currency on cash and cash equivalents | 144 | 105 |
| Net increase in cash and cash equivalents | 1,821 | 3,296 |
| Cash and cash equivalents at beginning of period | 19,492 | - |
| Cash and cash equivalents at end of period | 21,313 | - |
Elicio Therapeutics, Inc. (ELTX)
Elicio Therapeutics, Inc. (ELTX)